Mutational signatures that are characterized by cytosine mutations in TC dinucleotides, which are reflective of APOBEC1 and relevant APOBEC3 activities in cancer genomes, have been detected in over 50% of cancers and most cancer types [14,15]. The gene discussed is APOBEC1; the disease is cancer.